Amazon cover image
Image from Amazon.com

Mosby's 2023 Nursing Drug Reference

By: Material type: TextTextDescription: 1504 pageISBN:
  • 9780323930727
Subject(s):
NLM classification:
  • QV39
Contents:
Selected New Drugs -- abametapir -- aducanumab-avwa -- afamelanotide -- anifrolumab-fnia -- asciminib -- atogepant -- avacopan -- avapritinib -- belumosudil -- belzutifan -- bempedoic acid -- brolucizumab-dbll -- difelikefalin -- dostarlimab-gxly -- eculizumab -- efavirenz/emtricitabine/tenofovir -- elapegademase-ivir -- elbasvir/grazoprevir -- elexacaftor/tezacaftor/ivacaftor and ivacaftor -- emtricitabine/rilpivirine/tenofovir alafenamide -- enalapril/hydrochlorothiazide -- ephedrine -- factor IX complex -- factor IX, human -- factor IX, recombinant -- finerenone -- fluocinolone -- fluocinonide -- lonapegsomatropin-tcgd -- loncastuximab tesirine-lpyl -- maribavir -- mobocertinib -- odevixibat -- ropeginterferon alfa-2b -- tisotumab vedotin-tftv -- vosoritide
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Shelving location Call number Status Date due Barcode Item holds
General Book General Book Kuakarun Nursing Library Processing unit QV39 M894 2023 (Browse shelf(Opens below)) Available 0000049483
Total holds: 0

Selected New Drugs -- abametapir -- aducanumab-avwa -- afamelanotide -- anifrolumab-fnia -- asciminib -- atogepant -- avacopan -- avapritinib -- belumosudil -- belzutifan -- bempedoic acid -- brolucizumab-dbll -- difelikefalin -- dostarlimab-gxly -- eculizumab -- efavirenz/emtricitabine/tenofovir -- elapegademase-ivir -- elbasvir/grazoprevir -- elexacaftor/tezacaftor/ivacaftor and ivacaftor -- emtricitabine/rilpivirine/tenofovir alafenamide -- enalapril/hydrochlorothiazide -- ephedrine -- factor IX complex -- factor IX, human -- factor IX, recombinant -- finerenone -- fluocinolone -- fluocinonide -- lonapegsomatropin-tcgd -- loncastuximab tesirine-lpyl -- maribavir -- mobocertinib -- odevixibat -- ropeginterferon alfa-2b -- tisotumab vedotin-tftv -- vosoritide

There are no comments on this title.

to post a comment.